As of 2025-12-20, the Relative Valuation of Krystal Biotech Inc (KRYS) is 133.15 USD. This relative valuation is based on P/E multiples. With the latest stock price at 240.80 USD, the upside of Krystal Biotech Inc based on Relative Valuation is -44.7%.
The range of the Relative Valuation is 74.66 - 200.01 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.2x - 29.2x | 25.2x |
| Forward P/E multiples | 28.8x - 39.4x | 36.0x |
| Fair Price | 74.66 - 200.01 | 133.15 |
| Upside | -69.0% - -16.9% | -44.7% |
| Date | P/E |
| 2025-12-18 | 34.02 |
| 2025-12-17 | 34.38 |
| 2025-12-16 | 34.78 |
| 2025-12-15 | 35.43 |
| 2025-12-12 | 35.67 |
| 2025-12-11 | 35.98 |
| 2025-12-10 | 34.95 |
| 2025-12-09 | 34.21 |
| 2025-12-08 | 34.12 |
| 2025-12-05 | 34.13 |
| 2025-12-04 | 32.36 |
| 2025-12-03 | 31.70 |
| 2025-12-02 | 31.35 |
| 2025-12-01 | 31.36 |
| 2025-11-28 | 31.78 |
| 2025-11-26 | 31.89 |
| 2025-11-25 | 31.63 |
| 2025-11-24 | 31.33 |
| 2025-11-21 | 30.91 |
| 2025-11-20 | 29.77 |
| 2025-11-19 | 29.76 |
| 2025-11-18 | 29.85 |
| 2025-11-17 | 30.36 |
| 2025-11-14 | 30.06 |
| 2025-11-13 | 29.34 |
| 2025-11-12 | 29.60 |
| 2025-11-11 | 29.60 |
| 2025-11-10 | 29.09 |
| 2025-11-07 | 28.86 |
| 2025-11-06 | 29.15 |
| 2025-11-05 | 29.14 |
| 2025-11-04 | 29.63 |
| 2025-11-03 | 28.85 |
| 2025-10-31 | 28.80 |
| 2025-10-30 | 27.57 |
| 2025-10-29 | 26.98 |
| 2025-10-28 | 27.65 |
| 2025-10-27 | 27.69 |
| 2025-10-24 | 27.14 |
| 2025-10-23 | 27.18 |
| 2025-10-22 | 27.18 |
| 2025-10-21 | 27.81 |
| 2025-10-20 | 28.57 |
| 2025-10-17 | 27.73 |
| 2025-10-16 | 27.46 |
| 2025-10-15 | 28.14 |
| 2025-10-14 | 27.42 |
| 2025-10-13 | 26.93 |
| 2025-10-10 | 26.46 |
| 2025-10-09 | 27.52 |